business π¬ Q-Line Biotech IPO: GMP & Grey Market Premium Spotted
Q-Line Biotech is launching its maiden book building IPO for 6253200 equity shares to raise Rs. 214.48 cr. The company, which develops diagnostic reagents, is based in India and has a price band of Rs. 326 - Rs. 343 per share. The IPO is open for subscription from May 21, 2026, and closes on May 25, 2026. Despite top-line growth, FY25 bottom line saw a setback due to accounting adjustments. Well-informed investors might consider moderate long-term funds for this issue. π